title: Acute EBV infection masquerading as "In-situ Follicular Lymphoma": a pitfall in the differential diagnosis of this entity.
abstract: We present the case of a 30 year-old man who was referred for evaluation of diffuse lymphadenopathy. Six weeks prior, he noticed darkening of his urine associated with pale stools, nausea and an eventual 30 lb weight loss within a month. The initial laboratory findings showed elevation of the liver enzymes. A CT scan showed mesenteric and periaortic lymphadenopathy with the largest lymph node measuring 2.8 cm. Other laboratory results were otherwise unremarkable (including a normal LDH) with the exception of positive serum antibodies against Epstein-Barr virus (EBV) associated antigens (IgM+ and IgG+). An excisional biopsy of 4 of the small neck lymph nodes showed a normal architecture with prominent follicles and an intact capsule. But, by immunohistochemistry two of the follicles showed aberrant coexpression of BCL-2, in addition to CD10 and BCL-6. In-situ hybridization for early Epstein-Barr virus mRNA (EBER) and immunohistochemistry for latent membrane protein-1 (LMP-1) stained both scattered positive cells, as well as BCL-2 positive B-cells. Although an original diagnosis of in-situ follicular lymphoma was favored at an outside facility, additional interphase fluorescence in situ hybridization (FISH) studies for t(14;18);(IGH-BCL2) rearrangement (performed on the BCL-2 + follicles microdissected from the tissue block; Abott probe dual colour fusion) and molecular studies (IGH gene rearrangement by PCR, also performed on the microdissected follicles) were negative. Serologic studies (positive EBV antibodies) and immunostains in conjunction with the molecular studies confirmed the reactive nature of the changes. Our case also shows direct immunopathogenic evidence of BCL-2 expression among the EBV-infected cells, which has to our knowledge not been previously documented in vivo. A diagnosis of EBV infection should, therefore, be considered when confronted with BCL-2 expression in germinal centers, particularly in younger individuals, as the diagnosis of FLIS may lead to extensive and invasive haematologic work-ups.
  The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1323656318940068.
authors.affiliation: Department of Pathology and Immunology, Washington University School of Medicine, 660 S, Euclid Avenue, Box 8118, St, Louis, MO 63110, USA. jfrater@path.wustl.edu.
authors.forename: Alejandro A
authors.initials: AA
authors.lastname: Gru
authors.forename: Friederike
authors.initials: F
authors.lastname: Kreisel
authors.forename: Eric
authors.initials: E
authors.lastname: Duncavage
authors.forename: TuDung T
authors.initials: TT
authors.lastname: Nguyen
authors.forename: Anjum
authors.initials: A
authors.lastname: Hassan
authors.forename: John L
authors.initials: JL
authors.lastname: Frater
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D004268:DNA-Binding Proteins / Q000032:analysis; D003937:Diagnosis, Differential; D018858:Germinal Center / Q000737:chemistry / Q000276:immunology / Q000473:pathology / Q000821:virology*; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D007244:Infectious Mononucleosis / Q000097:blood / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology / Q000821:virology; D008197:Lymph Node Excision; D008224:Lymphoma, Follicular / Q000737:chemistry / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D008297:Male; D015260:Neprilysin / Q000032:analysis; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D051560:Proto-Oncogene Proteins c-bcl-6
chemical_list: D000914:Antibodies, Viral; C084103:BCL6 protein, human; D014408:Biomarkers, Tumor; D004268:DNA-Binding Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D051560:Proto-Oncogene Proteins c-bcl-6; D015260:Neprilysin